Our policies · Clinical decisions

How our doctors make clinical decisions.

Clinique Alpa is registered with the Care Quality Commission (CQC). Every appointment starts with a clinical assessment by a GMC-registered doctor, and every decision that follows is the doctor’s, made on the basis of that assessment and UK clinical guidance.

The principle

Assessment first, always.

Any advice, referral, letter or treatment decision is made by the doctor on the basis of a clinical assessment and UK clinical guidance. Our doctors do not provide any treatment on demand, and booking an appointment never guarantees a particular outcome.

If a doctor considers that a treatment is appropriate, they will discuss it with you during your appointment, explain the options honestly, and agree the next steps with you. Equally, if the safest answer is reassurance, a period of monitoring, or a referral elsewhere, that is what we will say.

In practice

Three commitments we work to.

01

Assessment comes first

Every appointment starts with a clinical assessment by a GMC-registered doctor. Nothing is decided before the doctor has listened to you and understood the clinical picture.

02

Nothing on demand

Our doctors do not provide any treatment on demand, and booking an appointment never guarantees a particular outcome. What you book is the doctor's time, care and honest judgement.

03

Honest limits

Some conditions require an in-person examination, baseline tests or ongoing monitoring before any decision can be made. Where that applies to you, we tell you plainly and direct you to the right appointment.

The standards

The same standards, wherever we see you.

Every clinical decision at Clinique Alpa is governed by the General Medical Council’s Good Medical Practice. The standard is the same whether the doctor sees you at the clinic or on a home visit: a doctor must not make a decision they cannot make responsibly.

Some conditions require an in-person examination, and we will tell you if that applies to you.

Joined-up care

Working with your NHS GP.

With your consent, we send a short summary of your consultation, including any treatment agreed, to your NHS GP so that your records stay joined up. Clinique Alpa provides private healthcare and does not replace your NHS GP.

Where we provide care

UK only patient services policy

Country served: United Kingdom only (England, Scotland, Wales and Northern Ireland).

Countries and territories not served: All countries and territories outside the United Kingdom. This includes the Republic of Ireland, Jersey, Guernsey, the Isle of Man and the British Overseas Territories.

Clinique Alpa provides clinical services only to patients physically located in the United Kingdom when receiving care. This restriction applies to consultations, treatment and prescribing, including remote consultations and follow up. A UK address or UK residency does not make a patient eligible for a remote consultation while they are abroad. Eligibility is based on location and the requirements of the individual service, not nationality.

For a remote consultation, patients must confirm when booking that they will be in the UK throughout the consultation. The clinician must confirm and document the patient's location at the start. If the patient is outside the UK, the clinical consultation must not proceed; the patient should be directed to an appropriate local service, including local emergency services where necessary.

Clinic appointments take place at our London clinic. Home visits are available only within the clinic's accepted service area. This policy does not mean that home visits or every other service are available throughout the UK. Individual services may have narrower geographical and clinical eligibility requirements, which continue to apply.

Where a medicine is prescribed and supplied through our partner pharmacy, delivery is restricted to addresses within the United Kingdom. We do not arrange shipment of medicines outside the UK.

The clinical lead is responsible for this policy. It should be reviewed annually and before any change to the countries served. Any extension of the service area requires a separate review and authorisation before services are offered or website wording is changed.

How we apply this policy

  • Clinic appointments take place at 466 Green Lanes, Palmers Green, London N13 5PA.
  • A video consultation can only be booked if you confirm that you will be in the UK during the call. The booking cannot be completed without that confirmation, and it is recorded with your booking.
  • Fees are charged in pounds sterling.
  • We check that our doctors' GMC registration and the clinic's CQC registration are current. If a registration is ever suspended, restricted or lapses, the affected doctor or service is taken off the booking system until it is restored.

How payments, prescriptions and medicine delivery stay within this policy is set out in our UK service, payment and medicine delivery safeguards.

Payments and delivery

UK service, payment and medicine delivery safeguards

Policy reference: CA/UK/SAFE/001 | Version 1.5 FINAL | Approved and effective 20 October 2026
Policy owner: Dr Mitesh Parmar, Clinical Director. Next annual review: 20 October 2027.

Download the UK service, payment and medicine delivery safeguards policyPDF, version 1.5, 2 pages, 231 KB

1. Purpose and scope

Clinique Alpa (Alpa Care Ltd t/a Clinique Alpa) is a CQC-registered clinic in London. Its services are offered only to patients physically in the United Kingdom: England, Scotland, Wales and Northern Ireland. Prescribing and medicine delivery arranged through the clinic are also restricted to the UK. All other countries and territories are outside the service area, including the Republic of Ireland, Jersey, Guernsey, the Isle of Man and British Overseas Territories. Narrower service limits continue to apply.

This geographical scope is a clinic service decision, not a claim that CQC or GMC universally prohibits overseas consultations. Requests from patients found to be abroad are handled as described in section 2. Any future extension of the countries served requires prior review of applicable registration, local law and indemnity, together with accurate website and certification disclosures.

2. Patient location and booking checks

Clinic appointments take place at the London premises. Home visits require a full address within the clinic's accepted service area. A correctly formatted postcode does not establish the country or the patient's physical location.

Video booking requires a recorded declaration that the patient will be in the UK during the consultation. Staff apply the same eligibility check before sending a manual payment link. At the start, the doctor verifies identity and confirms and records the patient's actual location. If the patient is outside the UK, the doctor issues no prescription, arranges no medicine and directs the patient to an appropriate healthcare provider where they are, including local emergency services where necessary. This contact is limited to establishing location and appropriate signposting; the clinic does not offer a routine overseas clinical consultation under this UK-only service.

3. Payment safeguards

For this pathway, Clinique Alpa charges for the consultation separately from the pharmacy's medicine and dispensing charges. Consultation fees are paid by card through the booking system or clinic card terminal, with manual payment links used where applicable. Patients cannot select and purchase prescription medicines on the clinic website.

Staff must check UK eligibility before issuing a manual payment link. Being found abroad does not, by itself, trigger an automatic refund. No prescription or medicine supply is arranged, and the patient is directed to local care. Any cancellation, rescheduling or refund is assessed under the published booking terms and applicable statutory rights, taking account of the service actually provided. A fee does not guarantee a prescription. Staff must record the reason, advice or signposting and any payment resolution.

A payment, UK billing address, bank card origin or payment in sterling does not establish physical location or clinical eligibility. The clinic relies on the booking declaration and manual checks; it does not claim automatic card country, billing country or IP blocking. SmartRx takes medicine payments separately following prescription review.

4. Prescribing and medicine delivery

Prescribing requires individual assessment by a GMC-registered doctor with a licence to practise, compliance with applicable law and clinic scope, and the patient being physically in the UK. Routine remote controlled-drug prescribing is excluded. Under CA-CD-REMOTE-001 v1.1, Dr Mitesh Parmar may exceptionally prescribe a single bridge of independently verified established treatment for an adult physically in England, after every required safeguard is met. Supply must be the minimum necessary, never more than seven days or the interval to agreed handover, whichever is shorter. New treatment, dose escalation and serial bridges are excluded. Medical cannabis, abortion medicines and prescribing without consultation remain excluded. Clinically justified off-label prescribing must meet applicable GMC and MHRA safeguards.

The dispensing partner is SmartRx Pharmacy, operated by Smartway Pharma Limited, 10 Lyon Road, London SW19 2RL, pharmacy registration 9010774. SmartRx approved the clinic account on 19 October 2026 and confirmed the partnership and certification directly to LegitScript on 20 October. Electronic prescribing is used only where lawful for the medicine. Private Schedule 2/3 community prescriptions in England use the original signed FP10PCD route with the required prescriber identification and particulars. Other schedules follow their applicable requirements. Confirm SmartRx's acceptance, lawful supply and timing for the particular prescription before issue.

Before fulfilment, clinic staff or the prescribing doctor must confirm the full UK delivery address with the patient and enter only a verified UK delivery address into the SmartRx portal. Delivery outside the UK is excluded, including Jersey, Guernsey, the Isle of Man, the Republic of Ireland and British Overseas Territories. Resolve destination uncertainty with the pharmacy before arranging supply. Do not arrange international shipment or knowingly facilitate overseas forwarding. These requirements apply to Clinique Alpa's pathway, not every SmartRx service.

5. Authorisation checks and suspension

The Clinical Director checks and records the clinic's relevant CQC registration, each doctor's GMC registration and licence, and the partner pharmacy's registration and certification before engagement, at renewal where applicable and when notified of a change or concern. Restrictions must be assessed against the actual service offered. Certification is distinct from statutory registration.

If an authorisation no longer permits an activity, stop affected new consultations, prescribing, bookings and payment requests. Disable outstanding payment links and clinic controlled access where possible; urgently request any necessary SmartRx access restriction and confirm action. Review affected appointments and arrange appropriate alternatives or refunds. Unaffected lawful services need not automatically stop.

If the pharmacy's registration is suspended or it otherwise lacks authority for the required supply, stop new referrals and immediately instruct the pharmacy to halt affected unfulfilled supplies, confirming action. No affected prescription may be dispensed or shipped without lawful authority. Review pending prescriptions individually with the pharmacist and follow regulatory directions, arranging cancellation, replacement or transfer to an authorised pharmacy where necessary, without duplicate supply or unsafe interruption of care. A lapse or suspension of LegitScript certification also requires pausing new referrals, requesting a hold on the clinic's pending supplies and resolving acceptable partner status with LegitScript. It is distinct from loss of statutory authority.

Apply the same stop and review process if a product becomes prohibited or cannot lawfully be supplied. Restart the affected activity only after the Clinical Director has documented that the necessary authority and safe arrangements are restored.

6. Records and review

Keep records of location and country eligibility checks, declined bookings, local signposting, payment resolutions, partner status checks and decisions to stop or restart an activity. Retain SmartRx's confirmation and certification evidence. Review this policy annually, before extending country coverage and after relevant regulatory, service or operational changes.

References

Hormone care

Hormone care: menopause HRT and hypothyroidism

Clinique Alpa provides care for menopause and perimenopause, and for primary hypothyroidism. We do not offer male hormone (androgen) replacement therapy.

Hormone treatment is started after a face to face clinical assessment. This includes relevant examination, cardiovascular checks, observations, ECG and baseline blood investigations. Tests are chosen for the individual clinical situation. Menopause in an otherwise healthy person aged 45 or over with typical symptoms is usually diagnosed clinically; routine hormone blood tests are not required to confirm it.

Telephone and video consultations can be used for advice, discussion of results and arranging further care. An unchanged prescription may exceptionally be continued remotely for an established, clinically stable patient when the doctor has adequate records and current monitoring, and there are no new concerns. Initiation and planned dose or route changes require face to face assessment under our clinic policy.

HRT is reviewed after approximately 3 months and then annually, or sooner if needed. Thyroid replacement requires blood test monitoring, with closer checks after starting or changing treatment and at least annual checks once stable. Treatment is not automatically stopped when symptoms improve or a blood result becomes normal.

We do not operate a hormone programme, membership or subscription, and we do not provide supplements as part of hormone care. Every prescription depends on an individual clinical decision.

Policy CA/CLIN/HRM/001 · Version 1.0 FINAL · Approved by Dr Mitesh Parmar, Clinical Director · Effective 20 October 2026 · Next review 20 October 2027.

Download the hormone care policies (PDF)Version 1.0 FINAL, 7 pages, 246 KB

Medicines

How medicines reach you.

A medicine is only ever supplied after a doctor has assessed you and decided it is clinically appropriate. If that happens after a video consultation, the medicine is dispensed by our partner pharmacy and delivered to your address in the United Kingdom.

Medicines used during an appointment at the clinic or on a home visit are obtained from licensed UK pharmaceutical wholesalers.

Our partner pharmacy

SmartRx Pharmacy.

SmartRx Pharmacy is run by Smartway Pharma Limited at 10 Lyon Road, London SW19 2RL. It is registered with the General Pharmaceutical Council (registration 9010774) and is certified by LegitScript. It is the only pharmacy we use to dispense medicines for our patients.

Visit the SmartRx Pharmacy website

Our limits

What we do not provide.

Routine remote controlled drug prescribing

Clinique Alpa does not offer routine remote controlled drug prescribing. Exceptionally, Dr Mitesh Parmar may consider a single short prescription to continue independently verified, established treatment for an adult physically in England. Every clinical, identity, records and lawful prescribing safeguard in the controlled drugs policy must be met. Supply is limited to the minimum clinically necessary, never more than seven days or the interval until the agreed handover, whichever is shorter. New treatment, dose escalation and successive prescriptions used to extend the bridge are excluded.

Medical cannabis

Clinique Alpa does not provide medical cannabis or cannabis based medicines.

Abortion services

Clinique Alpa does not provide abortion services or medicines to end a pregnancy. If you need this care, contact your NHS GP or a sexual health service.

Care outside the United Kingdom

We do not provide consultations, treatment or medicines to anyone outside the United Kingdom.

Medicines without a consultation

A medicine is never supplied on request or chosen in advance. A doctor decides only after assessing you.

Clinical policies

Our published policies.

IV medicines and fluids policy: how a doctor assesses adults before fluids, iron or standalone vitamin C are given into a vein, and how products, preparation, monitoring and emergencies are controlled. Policy CA-CLIN-SOP-IV-001 version 2.5, with supporting SOPs CA-CLIN-SOP-IV-002 version 1.4 (preparation, administration and monitoring), CA-CLIN-SOP-IV-003 version 1.4 (adverse events, emergency response and aftercare) and CA-CLIN-SOP-IV-004 version 1.4 (procurement, traceability, alerts and recalls). These final documents were updated on 23 October 2026 and retain their approval history of 22 October 2026. Review is due on 22 October 2027 or earlier after a relevant trigger. The policy describes the established clinic service and the records used to support its clinical governance.

Controlled-drugs remote prescribing policy: public summary: the seven-day bridging exception and its safeguards. Policy CA-CD-REMOTE-001, version 1.1, and public summary CA-CD-REMOTE-001-PUB, version 1.2, approved by Dr Mitesh Parmar on 20 October 2026, first review due 20 January 2027. Policy in force from 20 October 2026. Exceptional bridging may be considered subject to all policy safeguards being met for each prescription.

UK service, payment and medicine delivery safeguards: patient location, payment, prescribing and medicine delivery checks for our UK only service. Policy reference: CA/UK/SAFE/001 | Version 1.5 FINAL | Approved and effective 20 October 2026.

Hormone care: menopause HRT and hypothyroidism: menopause and perimenopause, and primary hypothyroidism; treatment started face to face, no male hormone (androgen) replacement therapy. Policy CA/CLIN/HRM/001 · Version 1.0 FINAL · Approved by Dr Mitesh Parmar, Clinical Director · Effective 20 October 2026 · Next review 20 October 2027.

Questions

If anything is unclear.

If you have a question about how a decision was made in your care, please contact us on 020 8882 8088 or enquiries@cliniquealpa.co.uk and we will explain. If you would like a concern handled formally, our complaints page explains how we deal with complaints and how long each stage takes.